Blood clots launch investigation over J&J vaccine
The Johnson & Johnson (J&J) COVID-19 vaccine is under investigation following the reports of rare (potentially dangerous) blood clots with leading pharmaceutical authorities recommending a delay in use. The Food and Drug Administration (FDA) released a joint statement with the U.S. Centers for Disease Control and Prevention (CDC) to “pause” the use of the Johnson & Johnson single-dose vaccine as they review the data of six cases of a severe and rare type of blood clot shortly after receiving the vaccine.
The recommended pause of Johnson & Johnson's vaccine, which makes up less than 5% of the recorded shots in arms in the U.S. to date, was “out of an abundance of caution,” says White House Covid-19 coordinator Jeff Zients https://t.co/IZjVQ8catD
— The Wall Street Journal (@WSJ) April 13, 2021
The six cases occurred among women patients between the ages of 18 and 48 with symptoms occurring 6 to 13 days after vaccination. These occurrences appear to be “extremely rare” while advising recipients of the J&J vaccine who experience symptoms including shortness of breath, severe headache, leg pain, or abdominal pain within three weeks of receiving the vaccine should contact their health care provider.
The White House will also be intervening in the growing issue with the J&J vaccine with the White House COVID-19 coordinator, Jeff Zients, working with federal and state partners to reschedule J&J vaccine patients to receive a Moderna or Pfizer vaccine. Johnson & Johnson disclosed in a statement they are aware of an extremely rare disorder including people with blood clots combined with low platelets in a small group of vaccine recipients.
The Biden administration is working with states to reschedule appointments for individuals who were in line to receive shots of Johnson & Johnson’s COVID-19 vaccine in the coming days. https://t.co/IRDEc9OPxt
— Michael Wilner (@mawilner) April 13, 2021
J&J maintains they’re working closely with health authorities and medical experts while supporting the open communication of this information to the public and health care professionals. J&J will also be reviewing potential cases with European health authorities and committed to proactively delay the rollout of the vaccine in Europe.
The Oxford-AstraZeneca vaccine is also experiencing similar concerns over rare blood clots with vaccines administered through the U.K., European Union (EU), and many other countries. Last week, the EU drug regulator said the benefits of the Oxford-AstraZeneca COVID-19 vaccine outweigh its risks.
Serena Williams Signs Docuseries Deal With Amazon
-
A transformative partnership to boost biodiversity, resilience, and gender equality in the face of climate change. The Philippines, in...
-
Claims by the ‘Crimea Combat Seagulls’ of poisoning two dozen Russian soldiers raise questions, prompting scrutiny and calls for...
-
According to the latest annual report from the Tokyo metropolitan government, Tokyo finds itself at the bottom of Japan’s...
-
A revealing look at the tensions, beliefs, and family dynamics within the British royal family In his latest book,...
-
A single-engine aircraft en route from the Czech Republic to Croatia crashes in western Austria, prompting an investigation into...
-
Historic Bust: Massive Counterfeit Coin Operation Exposed, Unveiling Unprecedented Scale of Fake Toonies in Canada. In a groundbreaking development,...
-
Global leaders from BRICS urge restraint, humanitarian truce, and diplomatic solutions to quell the Israel-Hamas tensions. In a landmark...
-
Secretary of State Antony Blinken calls for de-escalation as fighting displaces millions and raises concerns for upcoming Congo elections....
-
The government is taking action to stop the spread of the bloodsucking pests. The South Korean government has launched...
-
Landmark ruling highlights ongoing tax challenges for short-term rental platforms in Italy In a significant development, an Italian judge...
-
Deportation Deadline Sparks Humanitarian Worries in Pakistan Pakistan’s government announced on Monday that almost 200,000 Afghan nationals have voluntarily...
-
Lessons Learned Shape Taiwan’s Preparedness in a Changing World Taiwan’s military has embarked on a comprehensive initiative to strengthen...